Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 6.1B | 5.9B | 6.5B | 5.7B |
| Cost of revenue | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | — | — | — | — |
| Other operating expenses | 174M | -776M | 183M | 166M |
| Operating income | — | — | — | — |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | 55M | 56M | 55M | 54M |
| Other income expense | 8M | 7M | 7M | 10M |
| Pretax income | 849M | 838M | 229M | 981M |
| Tax provision | 173M | 171M | 17M | 223M |
| Net income | 676M | 667M | 212M | 758M |
| Basic EPS | — | — | — | — |
| Diluted EPS | — | — | — | — |
| Basic average shares | — | — | — | — |
| Diluted average shares | — | — | — | — |
| EBITDA | — | — | — | — |
| Net income from continuing op. | 849M | 838M | 229M | 981M |
| Minority interests | — | 0 | -5M | -8M |
| Preferred stock dividends | — | — | — | — |